Maintenance & Long-Term Success: Once you reach your goal weight, we offer a Maintenance Package to help you transition smoothly and prevent rebound weight gain
Rybelsus for cardiovascular health The SOUL trial found that Rybelsus reduced cardiovascular risk by 14% compared to placebo over 4 years
These FDA-approved treatments undergo rigorous testing, ensuring effectiveness and safety
(linked Retatrutide study) Loomba R, et al
By purchasing from our website, you acknowledge and agree to the following conditions: Research Use Only - All peptides, compounds, and related products are supplied exclusively for scientific research, analytical testing, and laboratory use by suitably qualified individuals or licensed organisations
For people with type 2 diabetes receiving concomitant insulin or sulfonylureas, there is a theoretical risk of hypoglycaemia based on class experience with GLP-1-based therapies